Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Deadly brain disease detected in Europe
reindeer
It is unclear currently if this is an isolated case or if the disease, which is difficult to detect is widespread in Europe.
Animal prion discovered in Norwegian reindeer

Scientists have detected a highly contagious and deadly animal brain disorder. A reindeer infected with chronic wasting disease (CWD) was found during a routine tracking expedition in southern Norway.

It is the first known case of the fatal disease both in Europe and the first occurrence in this species worldwide, the journal Nature reports. Previously thought to be restricted to deer, elk and moose in North America and South Korea, the disease is shed through saliva, urine and faeces. It is unclear currently if this is an isolated case or if the disease, which is difficult to detect is widespread in Europe.

CWD occurs when cellular proteins (prions) become misshapen and aggregate predominantly in the brain causing behaviour changes, weight loss and coordination problems. As with the similar bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease, CWD is incurable and fatal.

Sylvie Benestad, animal disease researcher at the Norwegian Veterinary Institute, performed a necropsy on the deer that was part of a free ranging herd in southern Norway’s alpine regions. She is quoted by Nature as saying: “It’s worrying of course, especially for animals, it’s a nasty disease”.

With importation an unlikely cause, suspicions are that the disease occurred spontaneously or jumped species from the sheep prion disease scrapie.

Glen Telling, prion disease researcher at Colorado State University in Fort Collins addressed the mystery of its origins. “The $64,000 question is what is the origin of this case of CWD in Europe. What we do know is that once CWD is detected in new locations, it typically takes a foothold in that location, and is difficult to eradicate.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.